200 related articles for article (PubMed ID: 22594400)
1. Adiponectin increases insulin content and cell proliferation in MIN6 cells via PPARγ-dependent and PPARγ-independent mechanisms.
Rao JR; Keating DJ; Chen C; Parkington HC
Diabetes Obes Metab; 2012 Nov; 14(11):983-9. PubMed ID: 22594400
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
3. Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle.
Li W; Tonelli J; Kishore P; Owen R; Goodman E; Scherer PE; Hawkins M
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1301-7. PubMed ID: 17213476
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and PPARγ: cooperative and interdependent actions of two key regulators of metabolism.
Astapova O; Leff T
Vitam Horm; 2012; 90():143-62. PubMed ID: 23017715
[TBL] [Abstract][Full Text] [Related]
5. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
6. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance.
Amin RH; Mathews ST; Camp HS; Ding L; Leff T
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E28-37. PubMed ID: 19843873
[TBL] [Abstract][Full Text] [Related]
8. Selective effects of PPARgamma agonists and antagonists on human pre-adipocyte differentiation.
Leyvraz C; Suter M; Verdumo C; Calmes JM; Paroz A; Darimont C; Gaillard RC; Pralong FP; Giusti V
Diabetes Obes Metab; 2010 Mar; 12(3):195-203. PubMed ID: 19895635
[TBL] [Abstract][Full Text] [Related]
9. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
Sommer M; Wolf G
Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
[TBL] [Abstract][Full Text] [Related]
11. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin--a key adipokine in the metabolic syndrome.
Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARγ-dependent manner in human adipocytes.
Tishinsky JM; Ma DW; Robinson LE
Obesity (Silver Spring); 2011 Feb; 19(2):262-8. PubMed ID: 20814411
[TBL] [Abstract][Full Text] [Related]
15. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
16. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes.
Kudoh A; Satoh H; Hirai H; Watanabe T
Life Sci; 2011 Jun; 88(23-24):1055-62. PubMed ID: 21514306
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism.
Landrier JF; Gouranton E; El Yazidi C; Malezet C; Balaguer P; Borel P; Amiot MJ
Endocrinology; 2009 Dec; 150(12):5318-25. PubMed ID: 19833717
[TBL] [Abstract][Full Text] [Related]
19. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
